Surgical Innovations Group plc
SUN.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 6.5% | -6.6% | -3% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 31.3% | 24.3% | 32.9% | 22.7% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Income | £0 | -£0 | -£0 | -£0 |
| % Margin | 1% | -8.8% | -2.1% | -4.6% |
| Other Income/Exp. Net | -£0 | -£0 | -£0 | -£0 |
| Pre-Tax Income | £0 | -£0 | -£0 | -£0 |
| Tax Expense | £0 | -£0 | £0 | -£0 |
| Net Income | £0 | -£0 | -£0 | -£0 |
| % Margin | 0.3% | -25.2% | -7.9% | -2.1% |
| EPS | 0 | -0.002 | -0.001 | -0 |
| % Growth | 100% | -220% | -400% | – |
| EPS Diluted | 0 | -0.002 | -0.001 | -0 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | £0 | -£0 | -£0 | £0 |
| % Margin | 6.1% | -19.8% | -1.9% | 1.5% |